[Pan-cancer analysis of MZB1 expression and its association with immune infiltration and clinical prognosis].
MZB1 is highly expressed in a variety of tumors, and its aberrant expression affects the occurrence and prognosis of many tumors, suggesting its potential as a novel tumor biomarker and immunomodulatory target.
Authors
- Li Zhai (ORCID: https://orcid.org/0000-0002-9844-1554)
- Yu‐Qing Pan (ORCID: https://orcid.org/0000-0002-8531-4281)
- Jianzhong Cao (ORCID: https://orcid.org/0000-0001-9652-4500)
- Xi Zhang (ORCID: https://orcid.org/0000-0002-0422-8980)
- Yu Zhang (ORCID: https://orcid.org/0000-0002-4870-3480)
- Haitao Li (ORCID: https://orcid.org/0000-0002-0577-2347)
Institutions
- Kunming Medical University (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-09-29
- DOI
- https://doi.org/10.12122/j.issn.1673-4254.2025.09.20
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article